FC
Fayerweather Charles Portfolio holdings
AUM
$57.2M
1-Year Est. Return
11.87%
1 Year Est. Return
+11.87%
AUM
$47.1M
AUM Growth
-$13.2M
(-22%)
Holding
55
Top Buys
| 1 | +$220K | |
| 2 | +$96.7K | |
| 3 | +$54.4K | |
| 4 |
Rockwell Automation
ROK
|
+$54.3K |
| 5 |
PayPal
PYPL
|
+$27.1K |
Top Sells
| 1 | +$355K | |
| 2 | +$341K | |
| 3 | +$261K | |
| 4 |
Apple
AAPL
|
+$234K |
| 5 |
J.M. Smucker
SJM
|
+$226K |
Sector Composition
| 1 | Healthcare | 26.65% |
| 2 | Technology | 21.76% |
| 3 | Industrials | 11.99% |
| 4 | Consumer Staples | 9.89% |
| 5 | Financials | 9.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Intel
INTC
$173B
| $794K | 1.69% |
14,650
-2,230
|
|
||
27
Amazon
AMZN
$2.44T
| $704K | 1.49% |
7,240
|
|
||
|
28
PayPal
PYPL
$56B
| $633K | 1.34% |
6,615
+283
|
|
||
29
Xylem
XYL
$33.9B
| $579K | 1.23% |
8,884
+260
|
|
||
30
Novo Nordisk
NVO
$214B
| $505K | 1.07% |
16,800
|
|
||
31
Fortive
FTV
$17.7B
| $430K | 0.91% |
12,318
+36
|
|
||
32
McCormick & Company Non-Voting
MKC
$18.4B
| $399K | 0.85% |
5,650
-300
|
|
||
33
Chevron
CVX
$300B
| $335K | 0.71% |
4,620
+750
|
|
||
34
Gilead Sciences
GILD
$154B
| $321K | 0.68% |
4,298
-1,781
|
|
||
35
Factset
FDS
$10.8B
| $306K | 0.65% |
1,175
-225
|
|
||
36
Colgate-Palmolive
CL
$63.7B
| $295K | 0.63% |
4,450
-110
|
|
||
37
Visa
V
$679B
| $290K | 0.62% |
1,800
-250
|
|
||
38
Fastenal
FAST
$48.6B
| $279K | 0.59% |
17,860
-600
|
|
||
39
Illumina
ILMN
$21B
| $274K | 0.58% |
1,027
|
|
||
40
Teleflex
TFX
$5.5B
| $249K | 0.53% |
850
|
|
||
41
Exxon Mobil
XOM
$498B
| $242K | 0.51% |
6,395
-750
|
|
||
42
EOG Resources
EOG
$56.1B
| $221K | 0.47% |
6,110
-175
|
|
||
43
UnitedHealth
UNH
$295B
| $220K | 0.47% |
+880
|
|
||
44
Qualcomm
QCOM
$187B
| $213K | 0.45% |
3,150
-200
|
|
||
45
AbbVie
ABBV
$403B
| – | – |
-2,400
|
|
||
46
Aflac
AFL
$57.8B
| – | – |
-3,800
|
|
||
47
Aon
AON
$75.2B
| – | – |
-975
|
|
||
48
Church & Dwight Co
CHD
$20.4B
| – | – |
-3,160
|
|
||
49
Illinois Tool Works
ITW
$72.6B
| – | – |
-1,450
|
|
||
50
Merck
MRK
$260B
| – | – |
-2,568
|
|